Somalogic Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| – | +73.6% | +46.1% | +19.7% | -16.3% | |
| – | -54.5% | +48.0% | +29.6% | +10.9% | |
| – | – | +44.7% | +12.7% | -38.1% | |
| – | -5.4% | +41.5% | +68.9% | -21.1% | |
| – | +10.1% | +110.7% | +98.2% | -16.3% | |
| – | +99.0% | +79.6% | +89.4% | +1.8% | |
| – | – | – | – | – | |
| – | – | -92.8% | +8,151.6% | – | |
| – | – | – | – | – | |
| – | – | -106.8% | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.